Our Lady of the Lake Heart & Vascular Institute recently performed Louisiana’s first transcatheter tricuspid valve replacement procedure using the EVOQUE system from Edwards Lifesciences, expanding treatment options for patients with tricuspid regurgitation.
Tricuspid regurgitation has traditionally only been treated using medication for its symptoms, not for the disease itself. The EVOQUE system has the potential to eliminate a patient’s tricuspid regurgitation all together.
“Transcatheter tricuspid valve replacement offers our patients with tricuspid regurgitation a revolutionary treatment for the deadly disease, which did not have effective treatment options before,” said Denzil Moraes, MD, Our Lady of the Lake Heart & Vascular Institute medical director. “We continue to seek out innovative technology and treatment options to improve our patients’ outcomes and quality of life.”